Tanay Kesharwani

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Newlink Genetics Corporation, Lankeanau Institute for Medical Research. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tanay Kesharwani. Retrieved from https://idiyas.com/inventor/tanay-kesharwani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 50.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Lake Katrine, NY (US) (2014 - 2015)
Ames, IA (US) (2016 - 2019)

Company Filing History:

8 out of 22

Newlink Genetics Corporation

patents

1 out of 1

Lankeanau Institute for Medical Research

patent

where one patent can have more than one assignee

Years Active: 2014-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10233190 - IDO inhibitors (2019-03-19),

2. 10047066 - IDO inhibitors (2018-08-14),

3. 9850248 - IDO inhibitors (2017-12-26),

4. 9388191 - Fused imidazole derivatives useful as IDO inhibitors (2016-07-12),

5. 9260434 - Fused imidazole derivatives useful as IDO inhibitors (2016-02-16),

6. 9174942 - IDO inhibitors (2015-11-03),

7. 8748469 - IDO inhibitors (2014-06-10),

8. 8722720 - Imidazole derivatives as IDO inhibitors (2014-05-13),

Title: The Innovative Contributions of Tanay Kesharwani

Introduction

Tanay Kesharwani is a prominent inventor based in Ames, Iowa, known for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, he has made remarkable strides in developing IDO inhibitors, which play a crucial role in modulating immune responses.

Latest Patents

Kesharwani's latest patents focus on IDO inhibitors and pharmaceutical compositions that are useful for various medical applications. These include treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression, enhancing the effectiveness of anti-cancer treatments, and addressing immunosuppression associated with infectious diseases. His innovative methods involve modulating the activity of indoleamine 2,3-dioxygenase, which is vital for improving patient outcomes in cancer and other medical conditions.

Career Highlights

Throughout his career, Tanay Kesharwani has worked with notable organizations such as Newlink Genetics Corporation and the Lankenau Institute for Medical Research. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Mario Mautino and Jesse Waldo, who have played a role in advancing his research initiatives. Their collaborative efforts have further enhanced the impact of Kesharwani's work in the pharmaceutical industry.

Conclusion

Tanay Kesharwani's innovative work in developing IDO inhibitors showcases his dedication to advancing medical science. His contributions have the potential to significantly improve treatment options for patients facing various health challenges.

Profile summary based on public USPTO records.